EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Gastrointestinal Symptoms in Systemic Sclerosis: Prevalence and Severity across Disease Subtypes and Autoantibody Profiles

Marina Vujovic Sestakov iD, Sretko Lukovic, Ivana Pavlovic, Maja Zlatanovic, Predrag Ostojic

Acta medica Lituanica · 22.07.2026 · 33 (1) · 161-168

DOI: 10.15388/amed.2026.33.1.13 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Acta medica Lituanica, online erschienen am 22.07.2026. Verfasst von Marina Vujovic Sestakov und 4 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Rheumatology, Belgrade, Serbia. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

This study aimed to evaluate the prevalence and severity of gastrointestinal (GI) symptoms in patients with systemic sclerosis (SSc), their impact on social functioning and emotional well-being, and to compare findings between patients with limited cutaneous systemic sclerosis (lcSSc) and diffuse cutaneous systemic sclerosis (dcSSc), as well as between patients positive for anticentromere (ACA) or anti-topoisomerase I (ATA) antibodies.Materials and methods: Forty-two consecutive patients with SSc were included: 31 with lcSSc and 11 with dcSSc. ACA antibodies were detected in 26 patients, and ATA antibodies in 16 patients. The UCLA SCTC GIT 2.0 self-assessment questionnaire was used to assess the severity of GI symptoms across seven subscales: reflux, distention/bloating, diarrhea, fecal soilage, constipation, social functioning, and emotional well-being.

Results

Symptoms of reflux (lcSSc/dcSSc = 64.5%/81.8%), distention/bloating (lcSSc/dcSSc = 61.3%/81.8%), constipation (lcSSc/dcSSc = 45.2%/45.5%), and fecal soilage (lcSSc/dcSSc = 6.4%/18.2%) were similarly frequent in lcSSc and dcSSc. Diarrhea was more common in dcSSc (45.5% vs. 16.1%, p = 0.04), with a higher median index value (0.25 vs. 0.00, p = 0.02), thus indicating more severe symptoms. No differences were observed in the prevalence or severity of GI symptoms between ACA- and ATA-positive patients. Median index values for social functioning and emotional well-being did not differ by the disease subtype or antibody status.

Conclusions

Diarrhea was more prevalent and more severe in patients with dcSSc, while other gastrointestinal manifestations showed no major differences between subtypes. Symptom prevalence and severity did not differ according to the antibody status, and their impact on social and emotional functioning was similar across the groups.

Schlagwörter

Stichwörter der Autor:innen

UCLA SCTC GIT 2.0gastrointestinal symptomspatient-reported outcomessystemic sclerosis

Autor:innen und Institutionen

  • Institute of Rheumatology, Belgrade, Serbia.
  • Faculty of Medicine, University of Belgrade, Belgrade, Serbia.

ORCID-Profile: Marina Vujovic Sestakov

Zitieren

APA

Vujovic Sestakov, M., Lukovic, S., Pavlovic, I., Zlatanovic, M., & Ostojic, P. (2026). Gastrointestinal Symptoms in Systemic Sclerosis: Prevalence and Severity across Disease Subtypes and Autoantibody Profiles. Acta medica Lituanica, 33(1), 161-168. https://doi.org/10.15388/amed.2026.33.1.13

Vancouver

Vujovic Sestakov M, Lukovic S, Pavlovic I, Zlatanovic M, Ostojic P. Gastrointestinal Symptoms in Systemic Sclerosis: Prevalence and Severity across Disease Subtypes and Autoantibody Profiles. Acta medica Lituanica. 2026;33(1):161-168. doi:10.15388/amed.2026.33.1.13

BibTeX
@article{VujovicSestakov2026,
  author = {Vujovic Sestakov, Marina and Lukovic, Sretko and Pavlovic, Ivana and Zlatanovic, Maja and Ostojic, Predrag},
  title = {Gastrointestinal Symptoms in Systemic Sclerosis: Prevalence and Severity across Disease Subtypes and Autoantibody Profiles},
  journal = {Acta medica Lituanica},
  year = {2026},
  volume = {33},
  number = {1},
  pages = {161--168},
  doi = {10.15388/amed.2026.33.1.13}
}
Kostenlos starten →